News | October 22, 2021
Gland Pharma PAT declines to Rs 302 crore QoQ in Q2FY22
The company’s wide therapeutic portfolio helped to sustain growth despite changing market demand
The company’s wide therapeutic portfolio helped to sustain growth despite changing market demand
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
The company reported total income of Rs.1215.73 crores during the period ended June 30, 2021.
Cenexi is committed to working closely with the ANSM to address the observations
Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
This is the ninth Covid-19 vaccine approved in India
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
Sputnik M is a new member of the Sputnik vaccines family
_256_384.jpg)
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
Subscribe To Our Newsletter & Stay Updated
